Oric Pharmaceuticals, Inc. · NASDAQ:ORIC

T. Rowe Price Associates Inc reported a 5.40% stake in Oric Pharmaceuticals, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

T. Rowe Price Associates Inc reported a 5.40% stake in Oric Pharmaceuticals, Inc., 5,387,783 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
5.40%
Shares
5,387,783
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.5.40%5,387,783

Source

View original at SEC

Related